Pinnacle Wealth Planning Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $939K | Buy |
8,743
+2,307
| +36% | +$248K | 0.12% | 99 |
|
|
2025
Q1 | $649K | Buy |
6,436
+180
| +3% | +$18.2K | 0.1% | 127 |
|
|
2024
Q4 | $559K | Sell |
6,256
-1,899
| -23% | -$170K | 0.08% | 144 |
|
|
2024
Q3 | $683K | Sell |
8,155
-168
| -2% | -$14.1K | 0.09% | 141 |
|
|
2024
Q2 | $641K | Sell |
8,323
-57
| -0.7% | -$4.39K | 0.09% | 140 |
|
|
2024
Q1 | $574K | Sell |
8,380
-243
| -3% | -$16.6K | 0.08% | 163 |
|
|
2023
Q4 | $498K | Sell |
8,623
-71
| -0.8% | -$4.11K | 0.08% | 177 |
|
|
2023
Q3 | $459K | Sell |
8,694
-40
| -0.5% | -$2.11K | 0.08% | 176 |
|
|
2023
Q2 | $472K | Sell |
8,734
-469
| -5% | -$25.4K | 0.08% | 177 |
|
|
2023
Q1 | $460K | Sell |
9,203
-6
| -0.1% | -$300 | 0.08% | 188 |
|
|
2022
Q4 | $426K | Buy |
9,209
+869
| +10% | +$40.2K | 0.08% | 194 |
|
|
2022
Q3 | $323K | Buy |
8,340
+170
| +2% | +$6.58K | 0.06% | 215 |
|
|
2022
Q2 | $304K | Buy |
8,170
+223
| +3% | +$8.3K | 0.05% | 245 |
|
|
2022
Q1 | $352K | Buy |
7,947
+755
| +10% | +$33.4K | 0.06% | 239 |
|
|
2021
Q4 | $305K | Buy |
7,192
+488
| +7% | +$20.7K | 0.06% | 257 |
|
|
2021
Q3 | $291K | Buy |
6,704
+41
| +0.6% | +$1.78K | 0.06% | 246 |
|
|
2021
Q2 | $285K | Sell |
6,663
-15
| -0.2% | -$642 | 0.07% | 236 |
|
|
2021
Q1 | $258K | Buy |
6,678
+1,298
| +24% | +$50.1K | 0.07% | 238 |
|
|
2020
Q4 | $193K | Buy |
+5,380
| New | +$193K | 0.05% | 288 |
|